Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that Gregory D. Perry and Zohar Loshitzer have been appointed to the company’s Board of Directors, effective today.
Mr. Perry, 51, is executive vice president and chief financial officer (CFO) of ImmunoGen, Inc., a publicly-traded biotechnology firm developing antibody-based anticancer therapeutics. Mr. Loshitzer, 54, is chief executive officer of Presbia, an ophthalmic-device firm, and is principal at Orchard Capital, a private equity firm.
“Greg and Zohar are a highly-valued addition to our Board of Directors,” said Gary Rabin, chairman and CEO of ACT. “Greg’s experience in fundraising and facilitating partnering deals in life sciences and Zohar’s background in successfully commercializing emerging technologies in medicine and other fields, as well as his background in finance, will be invaluable for ACT as there are many major milestones in front of us.”
Prior to joining ImmunoGen in January 2009, Mr. Perry was CFO of Elixer Pharmaceuticals, where he was deeply involved in partnering and fundraising, and before that he was CFO of Domantis, Ltd., a biotechnology company that was acquired by GlaxoSmithKline in 2006. Prior to that, he was senior vice president of finance and CFO of Transkaryotic Therapies, Inc. (TKT) until its acquisition by Shire plc. in 2005, and before that was with PerkinElmer and General Electric.Mr. Loshitzer previously was president, CEO and founder Universal Telecom Services (UTS). He is a co-founder of J2 Global Communications, a Nasdaq-listed company, and co-founder and former managing director of Life Alert Emergency Response, Inc. He currently serves as a managing director of Orchard Telecom, Inc., and as a board member of Environmental Solutions Worldwide, Inc. (ESW), a publicly-traded company engaged through its wholly-owned subsidiaries in the design and development of proprietary catalytic emission conversion, control and support products and technologies for the international transportation, construction and utility markets. He has also served as a board member to MAI Systems Corporation, an AMEX-listed company.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV